Clinical trial
A Study to Assess Efficacy Over Placebo and Speed of Onset of Pain Relief of New Paracetamol and Caffeine Tablets as Compared to Ibuprofen in Episodic Tension Type Headache
NCT01842633 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Assess Efficacy Over Placebo and Speed of Onset of Pain Relief of New Paracetamol and Caffeine Tablets as Compared to Ibuprofen in Episodic Tension Type Headache
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- April 1, 2013
- Completion date
- March 31, 2015
- Enrollment
- 365 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.